Aging-sensitive cellular and molecular mechanisms associated with skeletal muscle hypertrophy

Journal of Applied Physiology

Volumn 100, Issue 4, 2006, Pages 1188-1203

  Haddad, Fadia ^a   Adams, Gregory R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gastrocnemius; Insulin responsive sequence 1; Insulin like growth factor I; Translation

Indexed keywords

CONTRACTILE PROTEIN; CYCLIN D1; DNA; INSULIN; MESSENGER RNA; MUSCLE PROTEIN; MYOSTATIN; PROTEIN KINASE B; RNA; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; SUPPRESSOR OF CYTOKINE SIGNALING 2; SUPPRESSOR OF CYTOKINE SIGNALING 3;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COMMUNICATION; CONTROLLED STUDY; DISEASE MARKER; EXERCISE; GASTROCNEMIUS MUSCLE; MALE; MOLECULAR MECHANICS; MUSCLE ATROPHY; MUSCLE FORCE; MUSCLE HYPERTROPHY; MUSCLE MASS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RNA TRANSLATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; WEIGHT BEARING;

AGING; ANIMALS; GENE EXPRESSION REGULATION; HYPERTROPHY; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MALE; MUSCLE, SKELETAL; MYOSTATIN; PHOSPHOPROTEINS; PHOSPHORYLATION; PHYSICAL CONDITIONING, ANIMAL; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, INBRED BN; RATS, INBRED F344; RECEPTOR, IGF TYPE 1; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 33646357762     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01227.2005     Document Type: Article

References (95)

1. Adams GR, Caiozzo VJ, Haddad F, and Baldwin KM. Cellular and molecular responses to increased skeletal muscle loading after irradiation. Am J Physiol Cell Physiol 283: C1182-C1195, 2002.
2. Adams GR, Cheng DC, Haddad F, and Baldwin KM. Skeletal muscle hypertrophy in response to isometric, lengthening and shortening training bouts of equivalent duration. J Appl Physiol 96: 1613-1618, 2004.
3. Adams GR and Haddad F. The relationships between IGF-1, DNA content, and protein accumulation during skeletal muscle hypertrophy. J Appl Physiol 81: 2509-2516, 1996.
4. Adams GR, Haddad F, and Baldwin KM. Time course of changes in markers of myogenesis in overloaded rat skeletal muscles. J Appl Physiol 87: 1705-1712, 1999.
5. Adams GR and McCue SA. Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats. J Appl Physiol 84: 1716-1722, 1998.
6. Alford EK, Roy RR, Hodgson JA, and Edgerton VR. Electromyography of rat soleus, medial gastrocnemius, and tibialis anterior muscle during hindlimb suspension. Exp Neurl 96: 635-649, 1987.
7. Alvarez JV and Frank DA. Genome-wide analysis of STAT target genes: elucidating the mechanism of STAT-mediated oncogenesis. Cancer Biol Ther 3: 1045-1050, 2004.
8. Arias EB, Gosselin LE, and Cartee GD. Exercise training eliminates age-related differences in skeletal muscle insulin receptor and IRS-1 abundance in rats. J Gerontol A Biol Sci Med Sci 56: 449-455, 2001.
9. Avruch J. Insulin signal transduction through protein kinase cascades. Mol Cell Biochem 182: 31-48, 1998.
10. Baumann AP, Ibebunjo C, Grasser WA, and Paralkar VM. Myostatin expression in age and denervation-induced skeletal muscle atrophy. J Musculoskelet Neuronal Interact 3: 8-16, 2003.
11. Bickel CS, Slade J, Mahoney E, Haddad F, Dudley GA, and Adams GR. Time course of molecular responses of human skeletal muscle to acute bouts of resistance exercise. J Appl Physiol 98: 482-488, 2005.
12. Bickel CS, Slade JM, Haddad F, Adams GR, and Dudley GA. Acute molecular responses of skeletal muscle to resistance exercise in able-bodied and spinal cord-injured subjects. J Appl Physiol 94: 2255-2262, 2003.
13. Blough ER and Linderman JK. Lack of skeletal muscle hypertrophy in very aged male Fischer 344 X Brown Norway rats. J Appl Physiol 88: 1265-1270, 2000.
14. Brown M and Hasser EM. Differential effects of reduced muscle use (hindlimb unweighting) on skeletal muscle with aging. Aging Clin Exp Res 8: 99-105, 1996.
15. Caiozzo VJ, Ma E, McCue SA, Smith E, Herrick RE, and Baldwin KM. A new animal model for modulating myosin expression by altered mechanical activity. J Appl Physiol 73: 1432-1440, 1992.
16. Carbia-Nagashima A and Arzt E. Intracellular proteins and mechanisms involved in the control of gp130/JAK/STAT cytokine signaling. IUBMB Life 56: 83-88, 2004.
17. Chakravarthy MV, Davis BS, and Booth FW. IGF-I restores satellite cell proliferative potential in immobilized old skeletal muscle. J Appl Physiol 89: 1365-1379, 2000.
18. Chomczynski P and Sacchi N. Single step method of RNA isolation by acid guanidimium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
19. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, and Rando TA. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433: 760-764, 2005.
20. Degens H and Alway SE. Skeletal muscle function and hypertrophy are diminished in old age. Muscle Nerve 27: 339-347, 2003.
21. Diffee GM, Caiozzo VJ, McCue SA, Herrick RE, and Baldwin KM. Activity-induced regulation of myosin isoform distribution: comparison of two contractile activity programs. J Appl Physiol 4: 2509-2516, 1993.
22. Diffee GM, McCue S, LaRosa A, Herrick RE, and Baldwin KM. Interaction of various mechanical activity models in regulation of myosin heavy chain isoform expression. J Appl Physiol 74: 2517-2522, 1993.
23. Edstrom E and Ulfhake B. Sarcopenia is not due to lack of regenerative drive in senescent skeletal muscle. Aging Cell 4: 65-77, 2005.
24. Flores-Morales A, Greenhalgh CJ, Norstedt G, and Rico-Bautista E. Negative regulation of GH receptor signaling. Mol Endocrinol. First published July 21, 2005; 10.1210/me.2005-0170.
25. Fluckey JD, Vary TC, Jefferson LS, Evans WJ, and Farrell PA. Insulin stimulation of protein synthesis in rat skeletal muscle following resistance exercise is maintained with advanced age. J Gerontol A Biol Sci Med Sci 51: 323-330, 1996.
26. Frontera WR, Suh D, Krivickas LS, Hughes VA, Goldstein R, and Roubenoff R. Skeletal muscle fiber quality in older men and women. Am J Physiol Cell Physiol 279: C611-C618, 2000.
27. Gomes MD, Lecker SH, Jagoe RT, Navon A, and Goldberg AL. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 98: 14440-14445, 2001.
28. Greenhalgh CJ, Bertolino P, Asa SL, Metcalf D, Corbin JE, Adams TE, Davey HW, Nicola NA, Hilton DJ, and Alexander WS. Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b). Mol Endocrinol 16: 1394-1406, 2002.
29. Greenhalgh CJ, Rico-Bautista E, Lorentzon M, Thaus AL, Morgan PO, Willson TA, Zervoudakis P, Metcalf D, Street I, Nicola NA, Nash AD, Fabri LJ, Norstedt G, Ohlsson C, Flores-Morales A, Alexander WS, and Hilton DJ. SOCS2 negatively regulates growth hormone action in vitro and in vivo. J Clin Invest 115: 397-406, 2005.
30. Grounds MD. Age-associated changes in the response of skeletal muscle cells to exercise and regeneration. Ann NY Acad Sci 854: 78-91, 1998.
31. Gual P, LeMarchand-Brustel Y, and Tanti JF. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87: 99-109, 2005.
32. Guttridge DC. Signaling pathways weigh in on decisions to make or break skeletal muscle. Curr Opin Clin Nutr Metab Care 7: 443-450, 2004.
33. Haddad F and Adams GR. Acute cellular and molecular responses to resistance exercise. J Appl Physiol 93: 394-403, 2002.
34. Haddad F, Qin AX, Zeng M, McCue SA, and Baldwin KM. Effects of isometric training on skeletal myosin heavy chain expression. J Appl Physiol 84: 2036-2041, 1998.
35. Haddad F, Roy RR, Zhong H, Edgerton VR, and Baldwin KM. Atrophy responses to muscle inactivity. I. Cellular markers of protein deficits. J Appl Physiol 95: 781-790, 2003.
36. Haddad F, Zaldivar FP, Cooper DM, and Adams GR. IL-6 induced skeletal muscle atrophy. J Appl Physiol 98: 911-917, 2005.
37. Hannan KM, Hannan RD, and Rothblum LI. Transcription by RNA polymerase I. Front Biosci 3: 376-398, 1998.
38. Hepple RT, Ross KD, and Rempfer AB. Fiber atrophy and hypertrophy in skeletal muscles of late middle-aged Fischer 344 X Brown Norway F1-hybrid rats. J Gerontol A Biol Sci Med Sci 59: 108-117, 2004.
39. Hornberger TA, Mateja RD, Chin ER, Andrews JL, and Esser KA. Aging does not alter the mechanosensitivity of the p38, p70S6k, and JNK2 signaling pathways in skeletal muscle. J Appl Physiol 98: 1562-1566, 2005.
40. Hornberger TA, Stuppard R, Conley KE, Fedele MJ, Fiorotto ML, Chin ER, and Esser KA. Mechanical stimuli regulate rapamycin-sensitive signaling by a phosphoinositide 3-kinase, protein kinase B and growth factor independent mechanism. Biochem J 380: 795-804, 2004.
41. Husom AD, Ferrington DA, and Thompson LV. Age-related differences in the adaptive potential of type I skeletal muscle fibers. Exp Gerontol 40: 227-235, 2005.
42. Janssen I, Shepard DS, Katzmarzyk PT, and Roubenoff R. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc 52: 80-85, 2004.
43. Jones DA and Rutherford OM. Human muscle strength training: the effects of three different regimes and the nature of the resultant changes. J Physiol 391: 1-11, 1987.
44. Kadi F, Charifi N, Denis C, and Lexell J. Satellite cells and myonuclei in young and elderly women and men. Muscle Nerve 29: 120-127, 2004.
45. Kawada S, Tachi C, and Ishii N. Content and localization of myostatin in mouse skeletal muscles during aging, mechanical unloading and reloading. J Muscle Res Cell Motil 22: 627-633, 2001.
46. Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, DiIorio A, Corsi AM, Rantanen T, Guralnik JM, and Ferrucci L. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol 95: 1851-1860, 2003.
47. Lee SJ. Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol 20: 61-86, 2004.
48. Leeuwenburgh C, Gurley CM, Strotman BA, and Dupont-Versteegden EE. Age-related differences in apoptosis with disuse atrophy in soleus muscle. Am J Physiol Regul Integr Comp Physiol 288: R1288-R1296, 2005.
49. Lexell J and Downham D. What is the effect of ageing on type 2 muscle fibres? J Neurol Sci 107: 250-251, 1992.
50. Lexell J, Downham DY, Larsson Y, Bruhn E, and Morsing B. Heavy-resistance training in older Scandinavian men and women: short- and long-term effects on arm and leg muscles. Scand J Med Sci Sports 5: 329-341, 1995.
51. Li M, Li C, and Parkhouse WS. Age-related differences in the des IGF-I-mediated activation of Akt-1 and p70 S6K in mouse skeletal muscle. Mech Ageing Dev 124: 771-778, 2003.
52. Lieskovska J, Guo D, and Derman E. Growth impairment in IL-6-overexpressing transgenic mice is associated with induction of SOCS3 mRNA. Growth Horm IGF Res 13: 26-35, 2003.
53. Lipman RD, Chrisp CE, Hazzard DG, and Bronson RT. Pathologic characterization of Brown Norway, Brown Norway X Fischer 344, and Fischer 344 X Brown Norway rats with relation to age. J Gerontol A Biol Sci Med Sci 51: 54-59, 1996.
54. Liu W, Thomas SG, Asa SL, Gonzalez-Cadavid N, Bhasin S, and Ezzat S. Myostatin is a skeletal muscle target of growth hormone anabolic action. J Clin Endocrinol Metab 88: 5490-5496, 2003.
55. Marcell TJ, Harman SM, Urban RJ, Metz DD, Rodgers BD, and Blackman MR. Comparison of GH, IGF-I, and testosterone with mRNA of receptors and myostatin in skeletal muscle in older men. Am J Physiol Endocrinol Metab 281: E1159-E1164, 2001.
56. McKiernan SH, Bua E, McGorray J, and Aiken J. Early-onset calorie restriction conserves fiber number in aging rat skeletal muscle. FASEB J 18: 580-581, 2004.
57. McPherron AC, Lawler AM, and Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature 387: 83-90, 1997.
58. Mercier C, Jobin J, Lepine C, and Simard C. Effects of hindlimb suspension on contractile properties of young and old rat muscles and the impact of electrical stimulation on the recovery process. Mech Ageing Dev 106: 305-320, 1999.
59. Mooney RA, Senn J, Cameron S, Inamdar N, Boivin LM, Shang Y, and Furlanetto RW. Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokin-emediated insulin resistance. J Biol Chem 276: 25889-25893, 2001.
60. Morris RT, Spangenburg EE, and Booth FW. Responsiveness of cell signaling pathways during the failed 15-day regrowth of aged skeletal muscle. J Appl Physiol 96: 398-404, 2004.
61. Morse CI, Thom JM, Reeves ND, Birch KM, and Narici MV. In vivo physiological cross-sectional area and specific force are reduced in the gastrocnemius of elderly men. J Appl Physiol 99: 1050-1055, 2005.
62. Moulias R, Meaume S, and Raynaud-Simon A. Sarcopenia, hypermetabolism, and aging. Z Gerontol Geriatr 32: 425-432, 1999.
63. Nair KS. Aging muscle. Am J Clin Nutr 81: 953-963, 2005.
64. Narici MV, Maganaris CN, Reeves ND, and Capodaglio P. Effect of aging on human muscle architecture. J Appl Physiol 95: 2229-2234, 2003.
65. Owino V, Yang SY, and Goldspink G. Age-related loss of skeletal muscle function and the inability to express the autocrine form of insulinlike growth factor-1 (MGF) in response to mechanical overload. FEBS Lett 505: 259-263, 2001.
66. Parkington JD, LeBrasseur NK, Siebert AP, and Fielding RA. Contraction-mediated mTOR, p70S6k, and ERK1/2 phosphorylation in aged skeletal muscle. J Appl Physiol 97: 243-248, 2004.
67. Parkington JD, Siebert AP, LeBrasseur NK, and Fielding RA. Differential activation of mTOR signaling by contractile activity in skeletal muscle. Am J Physiol Regul Integr Comp Physiol 285: R1086-R1090, 2003.
68. Porter MM. The effects of strength training on sarcopenia. Can J Appl Physiol 26: 123-141, 2001.
69. Prod'homme M, Balage M, Debras E, Farges MC, Kimball S, Jefferson L, and Grizard J. Differential effects of insulin and dietary amino acids on muscle protein synthesis in adult and old rats. J Physiol 563: 235-248, 2005.
70. Rantanen T. Muscle strength, disability and mortality. Scand J Med Sci Sports 13: 3-8, 2003.
71. Reiter AK, Anthony TG, Anthony JC, Jefferson LS, and Kimball SR. The mTOR signaling pathway mediates control of ribosomal protein mRNA translation in rat liver. Int J Biochem Cell Biol 36: 2169-2179, 2004.
72. Rui L, Aguirre V, Kim JK, Shulman GI, Lee A, Corbould A, Dunaif A, and White MF. Insulin/IGF-1 and TNF-α stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest 107: 181-189, 2001.
73. Sacheck JM, Ohtsuka A, McLary SC, and Goldberg AL. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. Am J Physiol Endocrinol Metab 287: E591-E601, 2004.
74. Schulte JN and Yarasheski KE. Effects of resistance training on the rate of muscle protein synthesis in frail elderly people. Int J Sport Nutr Exerc Metab 11, Suppl: 111-118, 2001.
75. Schultz E and Lipton BH. Skeletal muscle satellite cells: changes in proliferation potential as a function of age. Mech Ageing Dev 20: 377-383, 1982.
76. Severgnini S, Lowenthal DT, Millard WJ, Simmen FA, Pollock BH, and Borst SE. Altered IGF-I and IGFBPs in senescent male and female rats. J Gerontol A Biol Sci Med Sci 54: 111-115, 1999.
77. Sherr CJ and Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9: 1149-1163, 1995.
78. Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, and Glass DJ. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14: 395-403, 2004.
79. Thomas G and Hall MN. TOR signaling and control of cell growth. Curr Opin Cell Biol 9: 782-787, 1997.
80. Thomason DB, Herrick RE, and Baldwin KM. Activity influences on soleus muscle myosin during rodent hindlimb suspension. J Appl Physiol 63: 138-144, 1987.
81. Tomas FM, Knowles SE, Chandler CS, Francis GL, Owens PC, and Ballard FJ. Anabolic effects of insulin like growth factor-1 (IGF-1) and an IGF-1 variant in normal female rats. J Endocrin 137: 413-421, 1993.
82. Turturro A, Witt WW, Lewis S, Hass BS, Lipman RD, and Hart RW. Growth curves and survival characteristics of the animals used in the Biomarkers of Aging Program. J Gerontol A Biol Sci Med Sci 54: 492-501, 1999.
83. Ueki K, Kondo T, and Kahn CR. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol Cell Biol 24: 5434-5446, 2004.
84. Welle S. Cellular and molecular basis of age-related sarcopenia. Can J Appl Physiol 27: 19-41, 2002.
85. Welle S, Bhatt K, Shah B, and Thornton C. Insulin-like growth factor-1 and myostatin mRNA expression in muscle: comparison between 62-77 and 21-31 yr old men. Exp Gerontol 37: 833-839, 2002.
86. Welle S, Brooks AI, Delehanty JM, Needler N, and Thornton CA. Gene expression profile of aging in human muscle. Physiol Genomics 14: 149-159, 2003.
87. Welle S, Thornton C, Jozefowicz R, and Statt M. Myofibrillar protein synthesis in young and old men. Am J Physiol Endocrinol Metab 264: E693-E698, 1993.
88. Welle S, Thornton C, and Statt M. Myofibrillar protein synthesis in young and old human subjects after three months of resistance training. Am J Physiol Endocrinol Metab 268: E422-E427, 1995.
89. Welle S, Totterman S, and Thornton C. Effect of age on muscle hypertrophy induced by resistance training. Gerontol A Biol Sci Med Sci 51: 270-275, 1996.
90. Whitman SA, Wacker MJ, Richmond SR, and Godard MP. Contributions of the ubiquitin-proteasome pathway and apoptosis to human skeletal muscle wasting with age. Pflügers Arch 450: 437-446, 2005.
91. Willis PE, Chadan S, Baracos V, and Parkhouse WS. Acute exercise attenuates age-associated resistance to insulin-like growth factor I. Am J Physiol Endocrinol Metab 272: E397-E404, 1997.
92. Yang SY and Goldspink G. Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation. FEBS Lett 522: 156-160, 2002.
93. Yarasheski KE. Exercise, aging, and muscle protein metabolism. Gerontol A Biol Sci Med Sci 58: 918-922, 2003.
94. Zachwieja JJ, Smith SR, Lovejoy JC, Rood JC, Windhauser MM, and Bray GA. Testosterone administration preserves protein balance but not muscle strength during 28 days of bed rest. J Clin Endocrinol Metab 84: 207-212, 1999.
95. Zhu M, deCabo R, Anson RM, Ingram DK, and Lane MA. Caloric restriction modulates insulin receptor signaling in liver and skeletal muscle of rat. Nutrition 21: 378-388, 2005.